Irritable Bowel Syndrome
News, opinions and meeting coverage in gastroenterology.
<ѻý>No Approval for Rifaximin in IBSѻý>
The FDA has indicated that, before the antibiotic drug rifaximin (Xifaxan) can be approved for treating irritable bowel syndrome, its manufacturer must provide data on how the agent should be used in retreating patients with recurrent symptoms, the company said.
Mar 08, 2011
<ѻý>Heart Risk Prompts FDA to Pull IBS Agent Tegaserod (Zelnorm)ѻý>
ROCKVILLE, Md. -- The FDA said today that Novartis has halted sales of tegaserod (Zelnorm), its agent for irritable bowel syndrome and constipation, following suggestions of a small increase in ischemic events, including angina and stroke, in those taking the drug.
Mar 30, 2007